ARCHIVES

Fisher Committee Suggest Program, NCI Changes To Enhance Surgical Oncology

This article is from The Cancer Letter archive.

Vol. 03 No. 13 | April 1, 1977

Download PDF Visit The Full Archive

Related Articles

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

September 26, 2014

Choice Of Reconstruction Can Depend On Who Consults

October 29, 2010

Tacoma Hospital Finds Cancer DRGs Are Profitable

February 17, 1984

In Brief: Breast Cancer Cells To Be Studied In Space; GrieshaberTo Head Drug Discovery Program

January 30, 1998

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

July 26, 2013

NIH Defines Misconduct

December 9, 1994